TABLE 3.

Clinical improvement for the B4DT post-treatment and at 6-month follow-up.

	Status at 6-month follow-up
Status at post-treatment	Remission	Response	No change	Deterioration	Total
Remission	9	1	0	0	10 (62.5%)
Response	4	0	1	0	5 (31.3%)
No change	0	0	1	0	1 (6.3%)
Deterioration	0	0	0	0	0
Total	13 (81.3%)	1 (6.3%)	2 (12.5%)	0	16

Treatment response was calculated based on the international consensus criteria (Mataix-Cols et al., 2016) which require a ≥35% reduction of the individual patient’s pre-treatment Y-BOCS score in order to be classified as a clinically relevant response. A patient is classified as remitted if, in addition to response, the post-treatment Y-BOCS score is ≤12 points.